Consumers Union, the policy and advocacy arm of Consumer Reports, has placed a full-page print ad in Washington, D.C.-based publication Politico, calling on Congress to close a loophole that allows dangerous devices to make it on the market without clinical testing.
The ad is running as the U.S. Senate prepares to vote on a bill this week to reauthorize the statute governing medical device oversight.
It specifically makes reference to two medical ...
continue reading...
Lawyers representing Pennsylvania and Johnson & Johnson both argued their side before a panel of seven Commonwealth Court justices on Wednesday, in a case involving allegations that Johnson & Johnson defrauded Pennsylvania out of millions of taxpayer dollars.
At issue is whether the company misled Medicaid officials about the risks of antipsychotic drug Risperdal and marketed it for unapproved uses, duping the state into improperly paying millions more for the drug ...
continue reading...
Commonwealth Court judges are scheduled to hear an appeal of the decision dismissing Pennsylvania’s 2008 lawsuit against Johnson & Johnson. The company is accused of fraudulently profiting from sales of the antipsychotic drug Risperdal through the Medicaid program.
According to an article in the Philadelphia Inquirer, Pennsylvania previously filed a lawsuit alleging that Johnson & Johnson tricked the state into paying millions more for the drug than it should have. But ...
continue reading...
According to the Mayo Clinic, urinary incontinence — or the loss of bladder control — is a common problem.
The condition ranges in severity, from occasionally leaking urine when you cough or sneeze, to having an urge to urinate so sudden and strong that you don’t get to a toilet in time.
Fortunately, urinary incontinence is a treatable condition. In most cases, simple lifestyle changes or medical treatment can ease discomfort or ...
continue reading...An entry on investment blog Seeking Alpha says that Johnson & Johnson is still trying to regain its footing after a disastrous series of recalls. But the blog advises investors that big salary cut for former CEO William Weldon, who has been demoted to chairman, is a good sign.
Alex Gorsky, the company’s new CEO, has said he plans to improve quality control at Johnson & Johnson.
Johnson & Johnson has instituted ...
continue reading...
According to a story in the Washington Post, Johnson & Johnson has applied to the U.S. Food and Drug Administration to get approval of another use for its anti-clotting drug Xarelto.
Johnson & Johnson currently markets Xarelto for reducing the risk of blood clots in patients after knee or hip replacement surgery, and reducing the risk of stroke and other blood clots in people with a type of irregular heartbeat. The ...
continue reading...
